Nuo Therapeutics, Inc. (AURX) › Total LiabilitiesNuo Therapeutics, Inc. (AURX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $8.98M2011: $6.80M2012: $6.33M2013: $19.44M2014: $40.26M2015: $43.13M2016: $1.57M2017: $941.2K2018: $1.06M2019: $1.49M2020: $665.0K2021: $673.1K2022: $856.0K2023: $838.7K2024: $675.8K2025: $2.80M$2.80M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$2.80M+314.7%2024$675.8K-19.4%2023$838.7K-2.0%2022$856.0K+27.2%2021$673.1K+1.2%2020$665.0K-55.2%2019$1.49M+40.5%2018$1.06M+12.4%2017$941.2K-40.1%2016$1.57M-96.4%2015$43.13M+7.1%2014$40.26M+107.1%2013$19.44M+207.2%2012$6.33M-6.9%2011$6.80M-24.3%2010$8.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share